Use of pemetrexed as first line treatment of advanced non-small cell lung cancer: The Czech Republic experience with the treatment of 237 patients (pts)

Lung Cancer ◽

10.1016/j.lungcan.2012.05.074 ◽

2012 ◽

Vol 77 ◽

pp. S38

Author(s):

Jana Skřičková ◽

Zdeněk Bortlíček ◽

Karel Hejduk ◽

Miloš Pešek ◽

Vítězslav Kolek ◽

...

Keyword(s):

Lung Cancer ◽

Czech Republic ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Line Treatment ◽

Small Cell Lung ◽

The Czech Republic ◽

First Line Treatment

Download Full-text

P2.14-34 Tyrosine-Kinase Inhibitors (TKI) in First-Line Treatment of 470 Patients with Non-Small Cell Lung Cancer (NSCLC) from the Czech Republic

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2019.08.1819 ◽

2019 ◽

Vol 14 (10) ◽

pp. S842-S843

Author(s):

J. Skřičková ◽

P. Májková ◽

M. Bařinová ◽

M. Pešek ◽

V. Kolek ◽

...

Keyword(s):

Lung Cancer ◽

Czech Republic ◽

Small Cell Lung Cancer ◽

Kinase Inhibitors ◽

Line Treatment ◽

Small Cell Lung ◽

The Czech Republic ◽

First Line Treatment

Download Full-text

Clinical Study of First-line Treatment of Small Cell Lung Cancer (SCLC) With Anlotinib Hydrochloride

Case Medical Research ◽

10.31525/ct1-nct03890055 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Clinical Study ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

Real-world outcomes for patients with metastatic non-small cell lung cancer according to first-line treatment

Revue d Épidémiologie et de Santé Publique ◽

10.1016/j.respe.2021.04.057 ◽

2021 ◽

Vol 69 ◽

pp. S36

Author(s):

Y. Belaroussi ◽

S. Cousin ◽

M. Carton ◽

M. Lebitasy ◽

L. Laborde ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

Crizotinib vs platinum‐based chemotherapy as first‐line treatment for advanced non‐small cell lung cancer with different ROS1 fusion variants

Cancer Medicine ◽

10.1002/cam4.2984 ◽

2020 ◽

Vol 9 (10) ◽

pp. 3328-3336 ◽

Author(s):

Haiyan Xu ◽

Quan Zhang ◽

Li Liang ◽

Junling Li ◽

Zhefeng Liu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Line Treatment ◽

Small Cell Lung ◽

Platinum Based Chemotherapy ◽

First Line Treatment

Download Full-text

Addition of atezolizumab to nab-paclitaxel plus carboplatin is a new standard option for the first-line treatment for non-squamous non-small cell lung cancer

Translational Cancer Research ◽

10.21037/tcr.2019.12.57 ◽

2019 ◽

Vol 8 (8) ◽

pp. E11-E14

Author(s):

Teppei Yamaguchi ◽

Toyoaki Hida

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

First-line treatment in advanced non-small-cell lung cancer: the emerging role of the histologic subtype

Expert Review of Anticancer Therapy ◽

10.1586/era.09.3 ◽

2009 ◽

Vol 9 (4) ◽

pp. 425-435 ◽

Author(s):

Marcello Tiseo ◽

Marco Bartolotti ◽

Francesco Gelsomino ◽

Andrea Ardizzoni

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Line Treatment ◽

Small Cell Lung ◽

Histologic Subtype ◽

First Line Treatment

Download Full-text

Clinical effect of erlotinib as first-line treatment for Asian elderly patients with advanced non-small-cell lung cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-010-1450-6 ◽

2010 ◽

Vol 67 (2) ◽

pp. 475-479 ◽

Author(s):

Xin-Hua Xu ◽

Jin Su ◽

Xiang-Yang Fu ◽

Feng Xue ◽

Qiao Huang ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Clinical Effect ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

Phase II study of carboplatin and 1-h intravenous etoposide and paclitaxel in a novel sequence as first-line treatment of patients with small-cell lung cancer

Lung Cancer ◽

10.1016/s0169-5002(02)00387-2 ◽

2003 ◽

Vol 39 (1) ◽

pp. 77-84 ◽

Author(s):

J.M Vieitez ◽

M Valladares ◽

M Gracia ◽

M Gonzalez-Barón ◽

G Martı́n ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

Cost-Minimization Analysis of Pembrolizumab Monotherapy Versus Nivolumab in Combination with Ipilimumab as First-Line Treatment for Metastatic PD-L1-Positive Non-small Cell Lung Cancer: A US Payer Perspective

PharmacoEconomics - Open ◽

10.1007/s41669-021-00288-1 ◽

2021 ◽

Author(s):

Nan Qiao ◽

Ralph Insinga ◽

Thomas Burke ◽

Gilberto Lopes

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Cost Minimization ◽

Line Treatment ◽

Small Cell Lung ◽

Payer Perspective ◽

First Line Treatment

Download Full-text

Durvalumab with or without tremelimumab vs platinum-based chemotherapy as first-line treatment for metastatic non-small cell lung cancer: MYSTIC

Annals of Oncology ◽

10.1093/annonc/mdy511.005 ◽

2018 ◽

Vol 29 ◽

pp. x40-x41 ◽

Author(s):

N.A. Rizvi ◽

B. Chul Cho ◽

N. Reinmuth ◽

K.H. Lee ◽

M.-J. Ahn ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Line Treatment ◽

Small Cell Lung ◽

Platinum Based Chemotherapy ◽

First Line Treatment

Download Full-text